We are pleased to be partner in the new H2020-funded project 'iNEXT-Discovery', in which EU-OPENSCREEN joins forces with the iNEXT-Discovery consortium to consolidate our cooperation with the structural biology community. Users will have access to the EU-OPENSCREEN fragment collection and will be able to screen the library at iNEXT-Discovery sites using NMR.
Fragments are compounds with relatively low molecular weights and target affinities, which can bind important sites on proteins (e.g. catalytic or ligand domains) not accessible to screening compounds. EU-OPENSCREEN is establishing a 1,000 fragment screening library in the framework of the EU-OPENSCREEN DRIVE project.
The press release can be found here.